Kings View Resolutions discusses a GPhC report that identifies “significant weaknesses” in governance, prescribing practice, advertising compliance and medicine supply.

The General Pharmaceutical Council (GPhC) has warned that pharmacies offering weight‑management medicines face escalating regulatory scrutiny, following a detailed review of inspections and concerns across Great Britain. The report identifies significant weaknesses in governance, prescribing practice, advertising compliance and medicine supply—issues that are now directly contributing to enforcement action and, in some cases, fitness to practise sanctions.

The review, covering inspection findings and more than 1,300 concerns, shows that weight‑management services—particularly those involving GLP‑1 receptor agonists—have become a high‑risk area for regulatory intervention. Pharmacies delivering these services without robust clinical and operational safeguards are increasingly likely to face improvement plans, conditions on registration, or referral for fitness to practise investigation.

Governance failures remain a major driver of regulatory risk

The GPhC found that many pharmacies lacked adequate risk assessments, up‑to‑date SOPs and clear clinical oversight. Standard 1.1 (risk management) and Standard 4.2 (safe and effective service delivery) were among the most frequently unmet standards.

Inspectors reported inconsistent documentation, poor record‑keeping, and limited evidence of structured follow‑up—issues that undermine safe prescribing and expose pharmacies to enforcement action.

Prescribing concerns and unsafe supply practices

Prescribing practice was the single largest area of concern. The GPhC identified repeated failures in the following:

• Independent verification of BMI and clinical suitability
• Appropriate dose titration and monitoring
• Communication with GPs
• Managing adverse effects and discontinuation
• Ensuring vulnerable groups are protected

Dispensing errors, incorrect quantities, expired stock and unsafe delivery practices—including cold‑chain failures—were also highlighted as recurring risks.

Advertising breaches continue despite clear regulatory warnings

The review notes widespread non‑compliance with advertising rules, including unlawful promotion of prescription‑only medicines, influencer marketing, discount codes and direct‑to‑consumer advertising. These breaches fall squarely within the scope of the joint CAP/MHRA/GPhC enforcement notice and have already triggered regulatory action.

Customer service issues now viewed as regulatory failings

Poor accessibility—such as non‑functioning phone lines, unanswered emails and delayed refunds—was a major theme in the concerns reviewed. The GPhC emphasises that inadequate communication is not merely a commercial issue but a standards compliance issue, particularly where it affects continuity of care.

Enforcement action and the link to fitness to practise sanctions

The GPhC has made clear that enforcement action taken against a pharmacy or pharmacy owner can escalate into fitness to practise proceedings for individual registrants.
According to legal commentary from GPhC defence specialists, enforcement action may lead to fitness to practise sanctions where:

• A pharmacist’s actions contributed to systemic failures
• There is evidence of unsafe or inappropriate supply
• Governance failures reflect a lack of professional judgement
• A registrant failed to act on known risks or concerns

Sanctions can include conditions, suspension or removal from the register.
For pharmacy owners, this reinforces the need for strong governance, documented oversight and proactive risk management.

What pharmacies should do now

The GPhC expects pharmacies to:

• Strengthen governance and maintain regularly reviewed risk assessments
• Ensure robust clinical oversight of prescribing and supply
• Verify BMI and eligibility independently
• Improve documentation and follow‑up
• Audit cold‑chain processes and delivery arrangements
• Remove unlawful advertising and ensure compliance with the enforcement notice
• Provide accessible, responsive customer service
• Conduct due diligence on third‑party prescribers and suppliers

Pharmacies that fail to address these areas risk enforcement action that may escalate to fitness to practise proceedings.

How Kings View Resolutions can support your pharmacy

With the GPhC sharpening its inspection methodology, many pharmacies are seeking expert support to ensure they remain compliant, resilient and inspection‑ready. Kings View Resolutions provides specialist legal and regulatory services tailored specifically to pharmacists and pharmacy owners.

Why pharmacies work with Kings View Resolutions

Whether your pharmacy is:

• Preparing for a GPhC inspection
• Responding to an improvement plan
• Managing regulatory concerns
• Conducting due diligence
• Strengthening internal governance

…mock inspections and expert regulatory support can make a critical difference.

Specialist services for pharmacists and pharmacy owners

Kings View Resolutions offers a comprehensive suite of services, including:

• Regulatory compliance
• Internal training
• Conducting internal investigations
• Preparing for independent investigations and reviews
• Mock inspections
• Whistleblowing services
• Crisis management

Experience you can rely on

With 30 years of combined experience and access to a network of industry experts, Kings View Resolutions is equipped to support even the most complex cases. The team works with sensitivity, timeliness and full transparency around fees, providing practical, actionable advice to help pharmacies achieve and maintain compliance with GPhC standards.

If your business is facing regulatory issues—or if you want to proactively strengthen compliance—speaking to one of their legal consultants can provide clarity and confidence.

Disclaimer: The accuracy and information of news stories published on this website is accurate on the date of publishing. We endeavour to update stories if information change. You can contact us with change and update requests. Where possible, we will link to sources. Content on this website is for guidance purposes only. We cannot accept any responsibility or liability whatsoever for any action taken, or not taken. You should seek the appropriate legal advice having regard to your own particular circumstances.